EXPERIENCE OF USING THE DRUG GEPON IN THE TREATMENT OF PATIENTS FOCAL SCLERODERMA

Authors

  • Abdullaev X.D Samarkand State Medical Institute
  • Abdullaev D.M Samarkand State Medical Institute
  • Narzikulov R.M Samarkand State Medical Institute
  • Tajieva M.U Samarkand State Medical Institute
  • Maxmudova P.B Samarkand State Medical Institute
  • Musinova Sh.Sh Samarkand State Medical Institute
  • Radjabova S.A Samarkand State Medical Institute

Keywords:

Localized scleroderma, combined treatment, gepon,

Abstract

We conducted a study of the effectiveness of the drug gepon in focal (localized) scleroderma. The main study group consisted of 19 patients with focal scleroderma aged 22 to 45 years. Among the patients, 11 men and 8 women. The duration of the disease varied from 3 to 10 years. Skin lesions were limited in nature, more often localized mainly on the face, chest, abdomen and lower leg. In addition to Gepon, patients were treated with traditional methods of treatment. We have obtained the following conclusions: the inclusion of the drug Gepon in the complex treatment of focal (localized) scleroderma contributes to a faster resolution of the pathological process and the restoration of skin elasticity.

Downloads

Published

2021-03-17

How to Cite

Abdullaev X.D, Abdullaev D.M, Narzikulov R.M, Tajieva M.U, Maxmudova P.B, Musinova Sh.Sh, & Radjabova S.A. (2021). EXPERIENCE OF USING THE DRUG GEPON IN THE TREATMENT OF PATIENTS FOCAL SCLERODERMA. ResearchJet Journal of Analysis and Inventions, 2(03), 60–63. Retrieved from https://reserchjet.academiascience.org/index.php/rjai/article/view/22

Issue

Vol. 2 No. 03 (2021): rjai

Section

Articles

Most read articles by the same author(s)